Infective Endocarditis Caused by Enterococcus faecalis treated with Continuous Infusion of Ampicillin without Adjunctive Aminoglycosides
|
|
- Sibyl Goodman
- 5 years ago
- Views:
Transcription
1 CASE REPORT Infective Endocarditis Caused by Enterococcus faecalis treated with Continuous Infusion of Ampicillin without Adjunctive Aminoglycosides Taku Ogawa, Masatoshi Sato, Shinsuke Yonekawa, Chiyo Nakagawa, Kenji Uno, Kei Kasahara, Koichi Maeda, Mitsuru Konishi and Keiichi Mikasa Abstract Aminoglycosides are useful antimicrobial agents for treating infective endocarditis; however, they occasionally cause troublesome side effects, such as nephrotoxicity and ototoxicity. We herein report a case of infective endocarditis caused by Enterococcus faecalis that was treated successfully with continuous infusion of ampicillin without adjunctive aminoglycosides. The serum ampicillin concentrations were higher than the minimal inhibitory concentration for the target strain. Although the use of ampicillin monotherapy is currently avoided because double β-lactam therapy is reportedly more effective, continuous penicillin administration remains an effective therapeutic choice for treating infective endocarditis. Key words: infective endocarditis, Enterococcus faecalis, ampicillin, continuous infusion, concentration () () Introduction Infective endocarditis is an important differential diagnosis for a fever of unknown origin. It should be diagnosed as quickly as possible and treated appropriately because it occasionally causes severe complications, such as vertebral osteomyelitis, infective aneurysms and abdominal abscesses. Frequently, penicillin places a burden on patients, doctors and nurses because the drug may be administered up to six times per day. Consequently, treatment with the continuous intravenous infusion of β-lactam antibiotics has recently attracted attention; however, few studies have so far reported the antibiotic concentrations in patients sera. The American Heart Association statement on Infective endocarditis: diagnosis, antimicrobial therapy and management of complications (1) recommends the use of the continuous infusion of penicillin G as an alternative to intermittent administration; however, continuous infusion of ampicillin is not currently recommended. Because there is no clear evidence regarding the inferiority of continuous infusion relative to intermittent administration, we therefore decided to evaluate continuous ampicillin infusion in a patient with infective endocarditis caused by Enterococcus faecalis. We measured the patient s serum ampicillin concentrations and performed blood cultures frequently to ensure the efficacy and safety of this therapy. We herein report a case of infective endocarditis caused by E. faecalis that was successfully treated with the continuous intravenous infusion of ampicillin alone. Case Report A 73-year-old man was admitted to our hospital in March 2008 presenting with a fever of unknown origin. The patient reported a history of a left cerebral infarction that had occurred 16 years previously followed by right hemiplegia. He was under prolonged anticoagulation therapy with warfarin for chronic atrial fibrillation. He had no remarkable family medical history and reported no smoking or alcohol consumption. The patient had previously been hospitalized for approximately five months for a right femoral neck fracture. He underwent right total hip arthroplasty, and gait rehabilitation Center for Infectious Diseases, Nara Medical University, Japan Received for publication June 20, 2012; Accepted for publication February 1, 2013 Correspondence to Dr. Taku Ogawa, t_ogawa@naramed-u.ac.jp 1131
2 Table 1. Laboratory Findings on the Day of Admission Table 2. The Susceptibility Test Results of the E. faecalis Obtained from the Patient Susceptibility of gentamicin and streptomycin was tested using the disc diffusion method. Other agents were tested using the microdilution. was initiated because no postoperative complications were observed. Approximately four months before being admitted to our hospital, he experienced gradual improvement in his daily activities. However, he simultaneously developed a fever of approximately 38. Initially, pyelonephritis was suspected due to macroscopic pyuria; however, no urine culture tests were performed. 81 and 61 days before admission to our hospital, blood culture results revealed the presence of E. faecalis. Piperacillin at a dose of 2 g twice daily was administered one day after diagnosis, which was changed five days later to flomoxef at a dose of 1 g twice daily after piperacillin failed to show any effects. When flomoxef failed to improve the patient s condition after three days, vancomycin was initiated at a dose of 0.5 g twice daily. However, vancomycin was also ineffective, and sulbactam-ampicillin at a dose of 3 g (1 g of sulbactam plus 2 g of ampicillin) twice daily was administered 43 days before the patient was admitted to our hospital. Despite these therapies, the patient s fever persisted. Gallium scintigraphy revealed an abnormal uptake in the patient s thoracic vertebra that was suggestive of vertebral osteomyelitis. His spinal tissue was collected and investigated pathologically and microbiologically. The pathological examination revealed severe inflammation; however, no organisms were detected on microbiological examinations. In view of the persistent fever, the patient was transferred to our hospital with a diagnosis of fever of unknown origin under ongoing sulbactam-ampicillin therapy. On admission, the patient had a body temperature of 38.0, a heart rate of 92 beats/min (irregular), a blood pressure of 104/56 mmhg and an oxygen saturation level of 97% (room air). Although the patient s respiratory rate was not measured precisely, it did not appear to be markedly elevated. The patient was conscious, without any evidence of mental disturbance; however, right hemiplegia was apparent. No signs of hemorrhage in the conjunctiva were observed, and the cervical lymph nodes were not palpable. No crackling sounds during inspiration or expiration, excessive heart sounds or murmurs or abnormalities in the abdomen were detected. An examination of the patient s entire skin did not reveal any signs indicative of infective endocarditis, and no evidence of spinal pain or heat was observed. The psoas sign was negative. The blood examination and urinalysis results showed some abnormalities (Table 1). Electrocardiography revealed atrial fibrillation. On day 2 of hospitalization, E. faecalis was detected in two sets of blood samples that were obtained on the day of admission. We initiated vancomycin at a dose of 1 g twice daily and gentamicin at a dose of 50 mg thrice daily as an empirical therapy for enterococcal bacteremia. However, after the susceptibility test results (Table 2) were obtained on day 3 of hospitalization, we decided to deescalate the antibiotic therapy and switch to a continuous infusion of ampicillin alone. On the seventh day of hospitalization, transthoracic echocardiography was performed to detect valve vegetation. We observed an abnormal echo around the mitral valve, which we suspected was due to vegetation. Accordingly, transesophageal echocardiography was performed on the following day. An oscillating vegetation measuring approximately 1132
3 Discussion Figure. Vegetation on anterior mitral valve leaflet with rapid swaying (size: approximately 11 mm in diameter). 11 mm in diameter attached to the anterior leaf of the mitral valve was observed (Figure). The patient was diagnosed with infective endocarditis caused by E. faecalis based on the modified Duke criteria (2). We confirmed the susceptibility of the targeted strain of E. faecalis to aminoglycosides using disc diffusion in accordance with the Clinical Laboratory and Standards Institute manual statement, Performance Standards for Antimicrobial Susceptibility Testing (M100-S21) (3). We found that the strain was highly resistant to gentamicin and sensitive to streptomycin (Table 2). We therefore decided to treat the patient with a continuous infusion of ampicillin alone at a dose of 12 g/d. The treatment protocol consisted of a continuous ampicillin infusion for 24 hours, followed by ampicillin (6 g) dissolved in 18 ml of saline administered at a rate of 1.7 ml/h using an infusion pump. The solution was changed twice per day. The patient s fever was alleviated within three days of initiating this treatment, and his blood cultures became negative after one week. We continued the treatment for 59 days until the erythrocyte sedimentation rate stabilized. Blood cultures were performed every week, and all culture results, except for those obtained on the day of admission, were negative. Transesophageal echocardiography was repeated on day 51 of hospitalization, which revealed that the vegetation had disappeared. No side effects, such as hyperkalemia, venous phlebitis or neutropenia, were observed during the course of treatment. The patient s serum ampicillin concentrations on days 33 and 40 of hospitalization (days 30 and 37 from the initiation of the continuous infusion) were 13.4 μg/ml and 15.0 μg/ ml, respectively. The serum ampicillin concentrations were measured using high performance liquid chromatography and were well above the minimum inhibitory concentration for the target E. faecalis. After completing the treatment, the patient underwent rehabilitation and was discharged from our hospital. Enterococcus spp. is one of the most important pathogens of infective endocarditis. In the American Heart Association s guidelines regarding infective endocarditis published in 2005 (1), the combined use of penicillin antibiotics and aminoglycoside antibiotics is recommended when no highlevel resistance to aminoglycosides is found. Administering 24 million units of penicillin G per day divided into six doses or via continuous infusion or 12 g of ampicillin per day divided into six doses is recommended. In the case reported here, E. faecalis exhibited high-level resistance to gentamicin and sensitivity to streptomycin. According to the guidelines, combination therapy with streptomycin plus ampicillin was recommended (1, 4). However, the frequent administration of streptomycin via intramuscular injection under anticoagulation entailed the possibility of complications, such as hematoma formation. For this reason, we avoided using streptomycin. The American Heart Association guidelines (1) recommend the use of continuous infusion of penicillin G. This recommendation is supported by animal studies, in which continuous infusion has been found not to be inferior to intermittent administration (5); however, there are no studies comparing continuous administration with intermittent infusion of ampicillin. We feared that penicillin G infusion into our patient s very thin vessels could easily cause phlebitis. Moreover, one study reported a tendency for missed doses to occur more frequently in nonintensive care unit settings than in intensive care unit settings when the doses are prescribed every four hours (6). The continuous infusion of β- lactam antibiotics in general does not appear to be inferior to intermittent administration (7-10). Furthermore, the effects correlate with the time above the minimum inhibitory concentration (11, 12). We came to the conclusion that a continuous infusion of ampicillin would be an acceptable method of treating this patient. Some reports state that the combined use of penicillin antibiotics and ceftriaxone is effective against infective endocarditis caused by Enterococcus spp. that exhibits high-level resistance to aminoglycosides (13-15). We did not adopt this double β-lactam treatment for this patient. However, considering the high failure rate of treatment of enterococcal infective endocarditis with ampicillin alone (16), adopting double β-lactam therapy could be worth considering at the present time. Generally, when continuous infusion is performed, the peaks and troughs of the serum concentration disappear and become consistently uniform; thus, the theoretical time above the minimal inhibitory concentration would be either 0% or 100%. Continuous infusion of penicillin antibiotics is considered to be effective only when the appropriate dosage is set. In our case, the serum ampicillin concentration accurately exceeded the minimal inhibitory concentration. It would therefore be useful in the future to study more such 1133
4 cases in order to examine the relationship between the serum concentration and the ampicillin dosage using the continuous infusion method. In cases treated with quinolones, maintaining a serum concentration within the mutant selection window (between the minimal inhibitory concentration and the mutant prevention concentration) for a long time can induce drug resistance (17, 18). In our treatment method, the serum concentration was above the minimal inhibitory concentration but was not very high compared with the intermittent method. The relationship between the mutant selection window and resistance induction to β-lactams is uncertain at this time; therefore, it is still impossible to assess whether this administration method contributes to resistance induction. We believe that further research is needed into the relationship between the serum concentrations of β-lactams and resistance formation. The guidelines regarding valvular disease issued by the American Heart Association in 2006 (19) state that early surgical intervention reduces the recurrence of infective endocarditis. In 2012, there were reports of randomized trials that support this view (20). However, even in the infective endocarditis clinical practice guidelines issued by the European Society of Cardiology in 2009 (21), early surgical intervention was deemed to be at an evidence level of IIb, which is not very high. Furthermore, a diameter 10 mm, which is a general indication for surgical intervention, is not a definitive criterion supported by randomized trials, and the standards applied to surgical intervention are not absolute. Taking this into account, we judged that our patient did not have a definite indication for surgical intervention. In addition, the heart surgery department of our hospital did not recommend immediate surgical intervention because there was no evidence of heart failure. Since the vegetation was found to have disappeared without any symptoms of embolism on the second transesophageal echocardiogram, we considered that surgery was not necessary. In the case reported herein, we successfully treated enterococcal infective endocarditis using continuous infusion of ampicillin only. We believe that continuous infusion is effective as an alternative administration method; however, it may still cause some problems. When the dosage is too low, the time above the minimal inhibitory concentration theoretically becomes 0%. Therefore, the relationship between the dosage of ampicillin and the serum concentration needs to be clarified in a larger group of patients. In conclusion, our findings indicate that continuous infusion of ampicillin at a sufficient dosage is an acceptable method when ampicillin is used as an antibiotic agent to treat infective endocarditis caused by Enterococcus spp. The authors state that they have no Conflict of Interest (COI). References 1. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111: e394-e434, Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 96: , Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, M100-S21, Henry NK, Wilson WR, Geraci JE. Treatment of streptomycinsusceptible enterococcal experimental endocarditis with combinations of penicillin and low- or high-dose streptomycin. Antimicrob Agents Chemother 30: , Eagle H, Fleischman R, Levy M. Continuous vs. discontinuous therapy with penicillin: the effect of the interval between injections on therapeutic efficacy. N Engl J Med 248: , Hughes DW, Frei CR, Maxwell PR, et al. Continuous versus intermittent infusion of oxacillin for treatment of infective endocarditis caused by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother 53: , Roberts JA, Webb S, Paterson D, Ho KM, Lipman J. A systematic review on clinical benefits of continuous administration of β- lactam antibiotics. Crit Care Med 37: , Buck C, Bertram N, Ackermann T, et al. Pharmacokinetics of piperacillin-tazobactam: intermittent dosing versus continuous infusion. Int J Antimicrob Agents 25: 62-67, Lau WK, Mercer D, Itani KM, et al. Randomized, open-label, comparative study of piperacillin-tazobactam administered by continuous infusion versus intermittent infusion for treatment of hospitalized patients with complicated intra-abdominal infection. Antimicrob Agents Chemother 50: , Pédeboscq S, Dubau B, Frappier S, et al. Comparison of 2 administration protocol (continuous or discontinuous) of a timedependent antibiotic, Tazocin. Pathol Biol (Paris) 49: , Nicolau DP. Pharmacodynamic optimization of beta-lactams in the patient care setting. Crit Care 12 (Suppl 4): S2, Chain E, Florey HW, Adelaide MB, et al. Penicillin as a chemotherapeutic agent. Lancet 236: , Gavaldà J, Torres C, Tenorio C, et al. Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides. Antimicrob Agent Chemother 43: , Gavaldà J, Len O, Miró JM, et al. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann Intern Med 146: , Euba G, Lora-Tamayo J, Murillo O, et al. Pilot study of ampicillin-ceftriaxone combination for treatment of orthopedic infections due to Enterococcus faecalis. Antimicrob Agents Chemother 53: , Geraci JE, Martin WJ. Antibiotic therapy of bacterial endocarditis. VI. Subacute enterococcal endocarditis: clinical, pathologic and therapeutic consideration of 33 cases. Circulation 10: , Zhao X, Drlica K. Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies. Clin Infect Dis 33: S147-S156, Zhao X, Drlica K. Restricting the selection of antibiotic-resistant mutants: measurement and potential uses of the mutant selection window. J Infect Dis 185: , Bonow RO, Carabello B, Chatterjee K, et al. ACC/AHA
5 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease). Circulation 114: e84-e231, Kang DH, Kim YJ, Kim SH, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med 28: , Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009). Eur Heart J 30: , The Japanese Society of Internal Medicine
Endocardite infectieuse
Endocardite infectieuse 1. Raccourcir le traitement: jusqu où? 2. Proposer un traitement ambulatoire: à partir de quand? Endocardite infectieuse A B 90 P = 0.014 20 P = 0.0005 % infective endocarditis
More informationInfections Amenable to OPAT. (Nabin Shrestha + Ajay Mathur)
3 Infections Amenable to OPAT (Nabin Shrestha + Ajay Mathur) Decisions regarding outpatient treatment of infections vary with the institution, the prescribing physician, the individual patient s condition
More informationDaniel C. DeSimone, MD Assistant Professor of Medicine
Daniel C. DeSimone, MD Assistant Professor of Medicine Faculty photo will be placed here Desimone.Daniel@mayo.edu 2015 MFMER 3543652-1 Infective Endocarditis Mayo School of Continuous Professional Development
More informationDr Babak Tamizi far MD. Assistant Professor Of Internal Medicine Al-Zahra Hospital Isfahan University Of Medical Sciences
Dr Babak Tamizi far MD. Assistant Professor Of Internal Medicine Al-Zahra Hospital Isfahan University Of Medical Sciences ١ ٢ ٣ A 57-year-old man presents with new-onset fever, shortness of breath, lower
More informationInfected cardiac-implantable electronic devices: diagnosis, and treatment
Infected cardiac-implantable electronic devices: diagnosis, and treatment The incidence of infection following implantation of cardiac implantable electronic devices (CIEDs) is increasing at a faster rate
More informationInfective Endocarditis Empirical therapy Antibiotic Guidelines. Contents
Infective Endocarditis Empirical therapy Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Group Additional author(s): as above Authors Division: Division of Clinical
More informationHeart on Fire: Infective Endocarditis. Objectives. Disclosure 8/27/2018. Mary McGreal DNP, RN, ANP-c, CCRN
Heart on Fire: Infective Endocarditis Mary McGreal DNP, RN, ANP-c, CCRN Objectives Discuss the incidence of infective endocarditis? Discuss the pathogenesis of infective endocarditis? Discuss clinical
More informationCase Report Daptomycin Failure for Treatment of Pulmonary Septic Emboli in Native Tricuspid and Mitral Valve
Case Reports in Infectious Diseases Volume 2013, Article ID 653582, 4 pages http://dx.doi.org/10.1155/2013/653582 Case Report Daptomycin Failure for Treatment of Pulmonary Septic Emboli in Native Tricuspid
More informationSBUH Aminoglycoside Dosing Protocol
Adult Aminoglycoside Dosing for Gram negative infections prior to available serum levels (Excludes patients with cystic fibrosis, OB GYN patients and surgical prophylaxis) Cr Cl 40 ml/min 5 7 mg/kg INT
More informationCase-based session. Infective Endocarditis. Applying the new guidelines. A case of large vegetation with neurological complication.
Case-based session. Infective Endocarditis. Applying the new guidelines. A case of large vegetation with neurological complication. María Nazarena Pizzi Hospital Universitari Vall d Hebron Barcelona. I
More informationPROSTHETIC VALVE ENDOCARDITIS Dr Bernard Prendergast DM FRCP EUROVALVE CONGRESS MADRID NOVEMBER 2013
PROSTHETIC VALVE ENDOCARDITIS Dr Bernard Prendergast DM FRCP EUROVALVE CONGRESS MADRID NOVEMBER 2013 Prosthetic Valve Endocarditis A Dangerous Disease Affects 1-6% of prosthetic valves Mechanical and biological
More informationINFECTION & INFLAMMATION IMAGING
INFECTION & INFLAMMATION IMAGING Radiopharmaceutical Drug Interactions & Other Interesting Case Studies MICHELLE RUNDIO, CNMT NCT MBA PCI NUCLEAR IN-111 WHITE BLOOD CELL IMAGING Interactions, Imaging Parameters
More informationJoshua Budhu M.S, Dorian Wood B.S, Marvin Crawford M.D, Khuram Ashraf M.D, Frederick Doamekpor M.D, Olufunke Akinbobuyi M.D
Accepted Manuscript Aerococcus Viridans Infectious Endocarditis Complicated by Splenic Infarction Joshua Budhu M.S, Dorian Wood B.S, Marvin Crawford M.D, Khuram Ashraf M.D, Frederick Doamekpor M.D, Olufunke
More informationApril 16, 09:00-09:15 중앙대학교 윤신원
April 16, 09:00-09:15 중앙대학교 윤신원 When to perform Echocardiography in IE? Vegetations?(pathologic Whatever the level hallmark) of suspicion Intracardiac abscess? Confirm or R/O at the Earliest opportunity.
More informationAntibiotic Treatment of Adults With Infective Endocarditis Due to Streptococci, Enterococci, Staphylococci, and HACEK Microorganisms
Antibiotic Treatment of Adults With Infective Endocarditis Due to Streptococci, Enterococci, Staphylococci, and HACEK Microorganisms Walter R. Wilson, MD; Adolf W. Karchmer, MD; Adnan S. Dajani, MD; Kathryn
More informationAntibiotic treatment of streptococcal and enterococcal endocarditis: an overview
European Heart Journal (1995) 16 {Supplement B), 75-79 Antibiotic treatment of streptococcal and enterococcal endocarditis: an overview P. FRANCIOLI Division of Hospital Preventative Medicine and Department
More informationClinical Guidelines for Use of Antibiotics. VANCOMYCIN (Adult)
VANCOMYCIN (Adult) Please always prescribe VANCOMYCIN in the Variable Dose Antibiotic section of the EPMA SUPPLEMENTARY drug chart (and add a placeholder on the electronic drug chart). 1 Background Vancomycin
More informationICU Volume 11 - Issue 3 - Autumn Series
ICU Volume 11 - Issue 3 - Autumn 2011 - Series Impact of Pharmacokinetics of Antibiotics in ICU Clinical Practice Introduction The efficacy of a drug is mainly dependent on its ability to achieve an effective
More informationEarly Surgery versus Conventional Treatment for Infective Endocarditis
T h e n e w e ngl a nd j o u r na l o f m e dic i n e original article Early Surgery versus Treatment for Infective Endocarditis Duk-Hyun Kang, M.D., Ph.D., Yong-Jin Kim, M.D., Ph.D., Sung-Han Kim, M.D.,
More informationHospital-wide Impact of Mandatory Infectious Disease Consultation on Staphylococcus aureus Septicemia
Hospital-wide Impact of Mandatory Infectious Disease Consultation on Staphylococcus aureus Septicemia Amanda Guth 1 Amy Slenker MD 1,2 1 Department of Infectious Diseases, Lehigh Valley Health Network
More informationNATIONAL HEART FOUNDATION HOSPITAL & RESEARCH INSTITUTE
Welcome INFECTIVE ENDOCARDITIS: WHERE WE ARE AT 2005? DR MD HABIBUR RAHMAN FCPS(Medicine) NATIONAL HEART FOUNDATION HOSPITAL & RESEARCH INSTITUTE DEFINITION OF INFECTIVE ENDOCARDITIS Infective endocarditis
More informationInitial Resuscitation of Sepsis & Septic Shock
Initial Resuscitation of Sepsis & Septic Shock Dr. Fatema Ahmed MD (Critical Care Medicine) FCPS (Medicine) Associate professor Dept. of Critical Care Medicine BIRDEM General Hospital Is Sepsis a known
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Kang D-H, Kim Y-J, Kim S-H, et al. Early surgery versus conventional
More informationINFECTIVE ENDOCARDITIS AMONGST INTRAVENOUS DRUG ABUSERS SEEN AT THE UNIVERSITY HOSPITAL, KUALA LUMPUR
Med. J. Malaysia Vol. 42 No. 4 December 1987 INFECTIVE ENDOCARDITIS AMONGST INTRAVENOUS DRUG ABUSERS SEEN AT THE UNIVERSITY HOSPITAL, KUALA LUMPUR R. JAYAMALAR MBBS, MRCP. "N. PARASAKTHI MBBS, MSc. "S.D.
More informationNew guidelines for the antibiotic treatment of streptococcal, enterococcal and staphylococcal endocarditis. D. C. Shanson
Journal of Antimicrobial Chemotherapy (1998) 42, 292 296 New guidelines for the antibiotic treatment of streptococcal, enterococcal and staphylococcal endocarditis JAC D. C. Shanson Microbiology Department,
More informationCase Studies in Complex Endocarditis
Case Studies in Complex Endocarditis Vera H. Rigolin, MD Professor of Medicine Northwestern University Feinberg School of Medicine Medical Director, Echocardiography Laboratory Northwestern Memorial Hospital
More informationCLINICAL USE OF GLYCOPEPTIDES. Herbert Spapen Intensive Care Department University Hospital Vrije Universiteit Brussel
CLINICAL USE OF GLYCOPEPTIDES Herbert Spapen Intensive Care Department University Hospital Vrije Universiteit Brussel Glycopeptides Natural Vancomycin introduced in 1958 Teicoplanin introduced in Europe
More informationVancomycin: Class: Antibiotic.
Vancomycin: Class: Antibiotic. Indications: Treatment of patients with infections caused by staphylococcal species and streptococcal Species. Available dosage form in the hospital: 1G VIAL, 500MG VIAL.
More informationChallenging clinical situation
Challenging clinical situation A young patient with prosthetic aortic valve endocarditis Gilbert Habib La Timone Hospital Marseille - France October 25 th 2014 Case report History of the disease Clinical
More informationBacterial Endocarditis
Objectives Bacterial Endocarditis John C. Rotschafer, Pharm. D. Professor College of Pharmacy University of Minnesota Identify which valves are commonly involved with endocarditis Identify common pathogens
More informationA study of clinical and etiological profile of infective endocarditis and its correlation with echocardiography in patients of rheumatic heart disease
International Journal of Advances in Medicine Sarkar A et al. Int J Adv Med. 2017 Oct;4(5):1323-1327 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20174177
More informationInfective Endocarditis Presenting as Acute Renal Failure and Unusual Complications
CASE REPORT Infective Endocarditis Presenting as Acute Renal Failure and Unusual Complications Luciano Pereira 1,2, Ana Machado 3, Jorge Oliveira 3,PedroAlmeida 4 and Paulo Bettencourt 3 Abstract Infective
More informationOverview. Clinical Scenario. Endocarditis: Treatment & Prevention. Prophylaxis The Concept. Jeremy D. Young, MD, MPH. Division of Infectious Diseases
Endocarditis: Treatment & Prevention Jeremy D. Young, MD, MPH Division of Infectious Diseases Clinical Scenario Patient with MVP scheduled to have wisdom teeth extracted. Has systolic murmur with mid-systolic
More informationManagement of infective endocarditis in children
Management of infective endocarditis in children Ashutosh Marwah, MD* Savitri Shrivastava, MD DM FAMS FACC* INTRODUCTION Infective endocarditis (IE) continues to remain a serious disease despite advances
More informationGeneral management of infective endocarditis
General management of infective endocarditis Team approach in infective endocarditis Gilbert Habib La Timone Hospital Marseille - France Eurovalves Barcelona 2017 The echolab «Heart Team" Infective Endocarditis
More informationTitle of image and video article Sub-Acute Leaflet Thrombosis: A Reversible Cause of Aortic Stenosis
Page 1 of 5 Title of image and video article Sub-Acute Leaflet Thrombosis: A Reversible Cause of Aortic Stenosis Authors Athina Chasapi, Adam Hobbs, Theodore Velissaris & Benoy N Shah. Wessex Cardiac &
More informationEndocarditis in the elderly
Endocarditis in the elderly Gilbert Habib Département de Cardiologie - Timone Marseille Eurovalves Barcelona 2017 Endocarditis in the octogenarian Gilbert Habib Département de Cardiologie - Timone Marseille
More informationPharmacologyonline 1: (2010) ewsletter Singh and Kochbar. Optimizing Pharmacokinetic/Pharmacodynamics Principles & Role of
Optimizing Pharmacokinetic/Pharmacodynamics Principles & Role of Cefoperazone Sulbactam Singh M*, Kochhar P* Medical & Research Division, Pfizer India. Summary Antimicrobial resistance is associated with
More informationPneumonia Community-Acquired Healthcare-Associated
Pneumonia Community-Acquired Healthcare-Associated Edwin Yu Clin Infect Dis 2007;44(S2):27-72 Am J Respir Crit Care Med 2005; 171:388-416 IDSA / ATS Guidelines Microbiology Principles and Practice of Infectious
More informationMICHIGAN MEDICINE GUIDELINES FOR TREATMENT OF URINARY TRACT INFECTIONS IN ADULTS
When to Order a Urine Culture: Asymptomatic bacteriuria is often treated unnecessarily, and accounts for a substantial burden of unnecessary antimicrobial use. National guidelines recommend against testing
More informationI (312) Mitral Regurgitation What Should You Know?
Mitral Regurgitation What Should You Know? Table of Contents What is Mitral Regurgitation? 3 What are the Symptoms? 4 What are the risks? 5 Who Gets Mitral Regurgitation? 6 Diagnosing Mitral Regurgitation
More informationAdult Inpatient Antibiogram. Antimicrobial Susceptibilities of Frequently Recovered Clinical Isolates. January to December 2016
Adult Inpatient Antibiogram Antimicrobial Susceptibilities of Frequently Recovered Clinical Isolates January to December 2016 Department of Pathology Camille Hamula, PhD Director, Clinical Microbiology
More informationInfective Endocarditis for Primary Care Physicians
Infective Endocarditis for Primary Care Physicians David N Gilbert, MD Disclosures Consultant to: Merck Pfizer Medicine Company Cempra 1 Introduction There are roughly 30,000 new cases of IE in the US
More informationMichael Stander, Pharm.D.
Michael Stander, Pharm.D. Endocarditis: Goals Epidemiology Presentation of acute and subacute. Diagnosis: What is Dukes Criteria and how do we approach the diagnosis of endocarditis? Treatment: Understand
More informationDepartment of Pharmacy Services, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102, USA; 2
Pathogens 2015, 4, 599-605; doi:10.3390/pathogens4030599 Article OPEN ACCESS pathogens ISSN 2076-0817 www.mdpi.com/journal/pathogens Assessing the Surrogate Susceptibility of Oxacillin and Cefoxitin for
More informationBlood stream candidiasis. R. Demeester, D. Famerée, B. Guillaume, JC. Legrand CHU Charleroi SBIMC 8th of November 2012
Blood stream candidiasis R. Demeester, D. Famerée, B. Guillaume, JC. Legrand CHU Charleroi SBIMC 8th of November 2012 62-year-old man: clinical history Fever for 10 days with peaks above 39 C, cough, orthopnea
More informationLessons from recent studies. João Gonçalves Pereira UCIP DALI
Lessons from recent studies João Gonçalves Pereira UCIP DALI 1 Patterns of Antimicrobial Activity Concentration C max Aminoglycosides Cmax/MIC>10 Metronidazol Area under the concentration curve Azithromycin
More informationYou Won t Believe What I Saw on. Disclosures. Goals. Dimensions 2013 October 18 th Michael Pfeiffer, MD. No Financial Disclosures
You Won t Believe What I Saw on that ECHO! Dimensions 2013 October 18 th Michael Pfeiffer, MD Disclosures No Financial Disclosures Goals Review unusual and unique echocardiographic images. Briefly present
More informationThe Challenge of Managing Staphylococcus aureus Bacteremia
The Challenge of Managing Staphylococcus aureus Bacteremia M A R G A R E T G R A Y B S P F C S H P C L I N I C A L P R A C T I C E M A N A G E R N O R T H / I D P H A R M A C I S T A L B E R T A H E A
More informationA pregnant patient with a prosthetic valve Giacomo Boccuzzi, MD, FESC
A pregnant patient with a prosthetic valve Giacomo Boccuzzi, MD, FESC Department of Invasive Cardiology, Ospedale San Giovanni Bosco, Turin, Italy *C.V. was born the 24th May 1980 Rheumatic fever during
More informationVancomycin Drug Class 1
Drug Class 1 Antibiotic glycopeptide Spectrum 1 Cross Sensitivities / Allergies 1 Refer to product monograph for complete spectrum Gram positive pathogens (e.g., S. aureus, Enterococcus, S. viridans, methicillinresistant
More informationDiagnosis and Treatment of Bacterial Endocarditis
Infectious diseases Board Review Manual Statement of Editorial Purpose The Hospital Physician Infectious Diseases Board Review Manual is a study guide for fellows and practicing physicians preparing for
More informationVANCOMYCIN DOSING AND MONITORING GUIDELINES
VANCOMYCIN DOSING AND MONITORING GUIDELINES NB Provincial Health Authorities Anti-Infective Stewardship Committee Approved: May 2017 GENERAL COMMENTS Vancomycin is a glycopeptide antibiotic with bactericidal
More informationBASIC KNOWLEDGE ABOUT INFECTIVE ENDOCARDITIS FOR CLINICIAN
BASIC KNOWLEDGE ABOUT INFECTIVE ENDOCARDITIS FOR CLINICIAN When should I suspect infective endocarditis? Antibiotic regimen Patient care after completion of treatment Prophylactic Regimens Prosthetic Valve
More informationInfective Endocarditis:
CME Workshop Infective Endocarditis: Prophylaxis, Diagnosis and Management Presented at a CME program, University of Manitoba, Winnipeg, Manitoba, December 2001. By Davinder S. Jassal, MD; and John M.
More informationMethicillin-Resistant Staphylococcus aureus (MRSA) S urveillance Report 2008 Background Methods
Methicillin-Resistant Staphylococcus aureus (MRSA) Surveillance Report 2008 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Department of Human Services
More informationEDUCATIONAL COMMENTARY VANCOMYCIN MONITORING
EDUCATIONAL COMMENTARY VANCOMYCIN MONITORING Commentary provided by: Julie Hall, MHS, MT (ASCP) Assistant Dean, College of Health Professions Assistant Professor, Medical Laboratory Science Grand Valley
More informationConsensus Statement on Infective Endocarditis / Abridged Version
CONSENSUS Consensus Statement on Infective Endocarditis / Abridged Version Argentine Society of Cardiology General Directors Secretary (Area of Regulations and Consensuses) Dr. Gustavo Giunta MTSAC 1.
More informationGuidelines for The Management of Infective Endocarditis
Guidelines for The Management of Infective Endocarditis By Dr. Sinan Butrus F.I.C.M.S Clinical Standards & Guidelines Kurdistan Board For Medical Specialties Infective endocarditis IE is an infection of
More informationTrust Guideline for the Use of Parenteral Vancomycin and Teicoplanin in Adults
A clinical guideline recommended for use: In: By: For: Division responsible for document: Key words: Names of document authors: Job titles of document authors: Name of document author s Line Manager: Job
More informationFull title of guideline INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS. control
Full title of guideline Author: Contact Name and Job Title Division and specialty Scope Explicit definition of patient group to which it applies (e.g. inclusion and exclusion criteria, diagnosis) Changes
More informationTAVI and Valve Replacement Thromboprophylaxis. Warren Prokopiw Pharmacy Resident
TAVI and Valve Replacement Thromboprophylaxis Warren Prokopiw Pharmacy Resident 2011-2012 Case Mr MW 76 yo Admitted 14 May for worsening CHF PMH: Aortic Stenosis, CVD (CABG x4 1980, PCI x3 stent 2008)
More informationOsteomieliti STEOMIE
OsteomielitiSTEOMIE Osteomyelitis is the inflammation of bone caused by pyogenic organisms. Major sources of infection: - haematogenous spread - tracking from adjacent foci of infection - direct inoculation
More informationClinical management of Staphylococcus aureus bacteremia an updated proposal of protocol
Clinical management of Staphylococcus aureus bacteremia an updated proposal of protocol Promotor : Prof. dr. W. Peetermans Second reader : Prof. dr. E. Van Wijngaerden Master s Thesis Internal Medicine
More informationSurgical Indications of Infective Endocarditis in Children
2016 Annual Spring Scientific Conference of the KSC April 15-16, 2016 Surgical Indications of Infective Endocarditis in Children Cheul Lee, MD Pediatric and Congenital Cardiac Surgery Seoul St. Mary s
More informationInfective endocarditis
Infective endocarditis This is caused by microbial infection of a heart valve (native or prosthetic), the lining of a cardiac chamber or blood vessel, or a congenital anomaly (e.g. septal defect). The
More informationEchocardiography after stroke - where to look
Echocardiography after stroke - where to look Vuyisile T. Nkomo, MD,MPH, FACC, FASE Joint Cardiac Imaging Society of South Africa/Mayo Clinic Echocardiography Workshop 2017 2016 MFMER slide-1 Disclosures
More informationInfective Endocarditis
Chapter 32 Infective Endocarditis Lisa B. Hightow and Meera Kelley The term infective endocarditis (IE) refers to infection of the endocardial surface of the heart and implies a physical presence of microganisms
More informationCase Report A Case of Infective Endocarditis and Pulmonary Septic Emboli Caused by Lactococcus lactis
Case Reports in Pediatrics Volume 2016, Article ID 1024054, 4 pages http://dx.doi.org/10.1155/2016/1024054 Case Report A Case of Infective Endocarditis and Pulmonary Septic Emboli Caused by Lactococcus
More informationCase Report Subacute Staphylococcusepidermidis Bacterial Endocarditis Complicated by Mitral-Aortic Intervalvular Fibrosa Pseudoaneurysm
Case Reports in Cardiology Volume 2012, Article ID 467210, 4 pages doi:10.1155/2012/467210 Case Report Subacute Staphylococcusepidermidis Bacterial Endocarditis Complicated by Mitral-Aortic Intervalvular
More informationEndocarditis: Medical vs. Surgical Treatment. Nabin K. Shrestha, MD, MPH Infectious Diseases
Endocarditis: Medical vs. Surgical Treatment Nabin K. Shrestha, MD, MPH Infectious Diseases Conflicts of interest Nothing to disclose 2 Complications of infective endocarditis Local complications Heart
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Dayer MJ, Jones S, Prendergast B, et al. Incidence
More informationAHA Scientific Statement
AHA Scientific Statement Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart
More informationAminoglycosides John A. Bosso, Pharm.D.
AMINOGLYCOSIDES Therapeutics/PHRMP-73 Aminoglycoside Mechanism of Action Aminoglycosides bind to 30s ribosomal subunit resulting in mistranslation of mrna thus disrupting protein synthesis. They are rapidly
More informationApport des recommandations européennes
Apport des recommandations européennes Gilbert Habib Cardiology Department- La Timone Marseille - France Bordeaux le 28 Juin 2011 Infective Endocarditis: a changing disease new high-risk subgroups IVDA
More informationDiagnostic strategy. Dr Pilar Tornos Hospital Vall d Hebron Barcelona
Diagnostic strategy Dr Pilar Tornos Hospital Vall d Hebron Barcelona Faculty disclosure Pilar Tornos I disclose the following financial relationships: Paid speaker for Recordati, Edwards. Diagnosis of
More informationWhen Should I Order a Stress Test or an Echocardiogram
When Should I Order a Stress Test or an Echocardiogram Updates in Cardiology 2015 March 7, 2015 Donald L. Lappé, MD, FAHA, FACC Chairman, Cardiovascular Department Medical Director, Intermountain Cardiovascular
More informationBSWH Pharmacist Continuing Education PART 5: Pharmacotherapy and Pharmacokinetics in Adults: Aminoglycosides and Vancomycin
BSWH Pharmacist Continuing Education 2015 PART 5: Pharmacotherapy and Pharmacokinetics in Adults: Aminoglycosides and Vancomycin Objectives Define basic pharmacodynamic and pharmacokinetic principles Describe
More informationKey words : Kingella denitrificans, diabetes mellitus, prosthetic valve endocarditis
Key words : Kingella denitrificans, diabetes mellitus, prosthetic valve endocarditis Table 1 Laboratory data on admission Fig. 1 Clinical course Table 2 Summary of 7 cases of Kingella denitrificans Endocarditis
More informationINFECTIOUS endocarditis (IE) is a
ORIGINAL INVESTIGATION Diagnosis of Infective Endocarditis Sensitivity of the Duke vs von Reyn Criteria Maija Heiro, MD; Jukka Nikoskelainen, MD, PhD; Jaakko J. Hartiala, MD, PhD; Markku K. Saraste, MD;
More informationClinicians and Facilities: RESOURCES WHEN CARING FOR WOMEN WITH ADULT CONGENITAL HEART DISEASE OR OTHER FORMS OF CARDIOVASCULAR DISEASE!!
Clinicians and Facilities: RESOURCES WHEN CARING FOR WOMEN WITH ADULT CONGENITAL HEART DISEASE OR OTHER FORMS OF CARDIOVASCULAR DISEASE!! Abha'Khandelwal,'MD,'MS' 'Stanford'University'School'of'Medicine'
More informationDeep venous thrombosis (DVT) occurs frequently
Ann Vasc Dis Vol.5, No.3; 2012; pp 328 333 2012 Annals of Vascular Diseases doi: 10.3400/avd.oa.12.00049 Original Article Deep Vein Thrombosis in Orthopedic Surgery of the Lower Extremities Masatoshi Motohashi,
More informationSredišnja medicinska knjižnica
Središnja medicinska knjižnica Kutleša M., Lepur D., Klinar I., Rudež I., Vincelj J., Bukovski S., Baršić B. (2009) Moraxella lacunata: a rare cause of infective endocarditis. Scandinavian Journal of Infectious
More informationEMPIRICAL TREATMENT OF SELECT INFECTIONS ADULT GUIDELINES. Refer to VIHA Algorithm for the empiric treatment of Urinary Tract Infection
URINARY TRACT Refer to VIHA Algorithm for the empiric treatment of Urinary Tract Infection and Asymptomatic Bacteriuria on the VIHA Intranet: https://intranet.viha.ca/departments/pharmacy/clinical_pharmacy/pages/infec
More information2018 CNISP HAI Surveillance Case definitions
2018 CNISP HAI Surveillance Case definitions The following case definitions for the surveillance of healthcare-associated infections (HAIs) are used by all acute-care hospitals that participate in the
More informationRochester Patient Safety C. difficile Prevention Collaborative: Long Term Care Antimicrobial Stewardship (funded by NYSDOH)
Rochester Patient Safety C. difficile Prevention Collaborative: Long Term Care Antimicrobial Stewardship (funded by NYSDOH) Clinical Practice Guideline* for the Diagnosis and Management of Acute Bacterial
More informationEnhanced EARS-Net Surveillance REPORT FOR 2012 DATA
Enhanced EARS-Net Surveillance REPORT FOR DATA 1 In this report Main results for Proposed changes to the enhanced programme Abbreviations Used Here BSI Bloodstream Infections CVC Central Venous Catheter
More informationRenal Unit. Catheter Related Bacteraemia Guidelines
Renal Unit Policy Manager Drew Henderson Policy Group Renal Unit Policy Established 21/01/2014 Policy Review Period/Expiry 21/01/2015 Last Updated 21/01/2014 This policy does apply to Medical/Dental Staff
More informationAminoglycosides. Not orally absorbed. Interact with negatively charged lipopolysaccharide on Gram- cell wall. Aminoglycoside properties
Aminoglycosides Tobramycin Kanamycin H2N Gentamicin Amikacin NHCOCHCH2CH2NH2 OH Aminoglycosides made of linked sugars. Decorated with many OH and NH2 groups, which render these compounds positively charged
More informationEnhanced EARS-Net Surveillance 2017 First Half
1 Enhanced EARS-Net Surveillance 2017 First Half In this report Main results for 2017, first half Breakdown of factors by organism and resistance subtype Device-association Data quality assessment Key
More informationUpdate on the prevention, diagnosis and management of Infective Endocarditis (IE)
Update on the prevention, diagnosis and management of Infective Endocarditis (IE) Dr.Ahmed Yahya Mohammed Alarhabi MD, MsC,FcUSM,FACC,MAHA Consultant Interventional Cardiologist Head of Cardiac Center
More informationEarly oral switch for antibiotic treatment of infective endocarditis
AEPEI: Association pour l Etude et la Prévention des Endocardites Infectieuses Early oral switch for antibiotic treatment of infective endocarditis Prof. Pierre Tattevin Infectious Diseases & ICU, INSERM
More informationTransient Cerebral Ischemic Attacks Associated With Subacute Bacterial Endocarditis
Transient Cerebral Ischemic Attacks Associated With Subacute Bacterial Endocarditis BY ROBERT G. SIEKERT. M.D., AND H. ROYDEN JONES, JR., M.D. Abstract: Transient Cerebral Ischemic A Hacks Associated with
More informationPharmacokinetics of daptomycin in a patient with severe renal failure not under dialysis
AAC Accepts, published online ahead of print on 1 April 2013 Antimicrob. Agents Chemother. doi:10.1128/aac.00230-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 Pharmacokinetics
More informationASHP Therapeutic Position Statements 623
ASHP Therapeutic Position Statements 623 Therapeutic Monitoring of Vancomycin in Adult Patients: A Consensus Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society
More informationDeaf or Dead? Is It Time To Drop Aminoglycosides For Dual β- Lactam Therapy In Enterococcal Infective Endocarditis?
Deaf or Dead? Is It Time To Drop Aminoglycosides For Dual β- Lactam Therapy In Enterococcal Infective Endocarditis? Omar J. OJ Martinez, Pharm.D. PGY- 1 Pharmacy Practice Resident Department of Pharmacy,
More informationSepsis and Infective Endocarditis
Sepsis and Infective Endocarditis Michal Holub Department of Infectious Diseases First Faculty of Medicine Charles University in Prague and University Military Hospital Bacteremia and Sepsis bacteremia
More informationSeptic Shock. Rontgene M. Solante, MD, FPCP,FPSMID
Septic Shock Rontgene M. Solante, MD, FPCP,FPSMID Learning Objectives Identify situations wherein high or low BP are hemodynamically significant Recognize complications arising from BP emergencies Manage
More informationMRSA Micro Scan Pos Combo 6J DADE BEHRING VCM
PKPD MRSA 1 1 2 1 1 2 17 1 26 17 3 16 vancomycinvcm methicillin-resistant Staphylococcus aureusmrsa 31 pharmacokineticpkparameter retrospective VCM 21 10 PK parameter Mann- Whitney U-test Cmax 37.1 µ gml29.942
More information